Agonist-dependent effects of mutations in the sphingosine-1-phosphate type 1 receptor
The sphingosine-1-phosphate type 1 (S1P 1) receptor is a new target in the treatment of auto-immune diseases as evidenced by the recent approval of FTY720 (Fingolimod). The ligand-binding pocket of the S1P 1 receptor has been generally characterised but detailed insight into ligand-specific differen...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2011-09, Vol.667 (1), p.105-112 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The sphingosine-1-phosphate type 1 (S1P
1) receptor is a new target in the treatment of auto-immune diseases as evidenced by the recent approval of FTY720 (Fingolimod). The ligand-binding pocket of the S1P
1 receptor has been generally characterised but detailed insight into ligand-specific differences is still lacking. The aim of the current study is to determine differences in ligand-induced S1P
1 receptor activation using an
in silico guided site-directed mutagenesis strategy. S1P
1 mutant receptors (modifications of residues Y98
2.57, R120
3.28, F125
3.33) were probed with a chemically diverse set of S1P
1 agonists (S1P, dihydro-S1P (dhS1P),
R-,
S- and racemic FTY720-P, VPC24191, SEW2871). Mutation of the R
3.28 residue generally results in a reduction of the potency of all ligands although the synthetic ligands including FTY720-P are less sensitive to these mutations. The Y
2.57F mutation does not affect the potency of any of the ligands tested, but for all ligands except FTY720-P a significant decrease in potency is observed at the Y
2.57A mutant. The F
3.33A mutation significantly decreased the potency of FTY720-P and is detrimental for SEW2871 and VPC24191. The non-aromatic endogenous ligands S1P and dhS1P are less affected by this mutation. Our
in silico guided mutagenesis studies identified new molecular determinants of ligand-induced S1P
1 receptor activation: 1) the flexibility of the polar head of the agonist to maintain a tight H-bond network with R
3.28 and 2) the ability of the agonist to make aromatic π-stacking interactions with F
3.33. Interestingly, FTY720-P has both chemical properties and is the only ligand that can efficiently activate the Y
2.57A mutant.
► The effect of the S1P
1 mutations studied are ligand-dependent. ► The sensitivity of ligands towards a mutation depends on the flexibility and aromaticity of a ligand. ► FTY720-P has both properties and is the only ligand that can efficiently activate the Y
2.57A mutant. |
---|---|
ISSN: | 0014-2999 1879-0712 |
DOI: | 10.1016/j.ejphar.2011.05.071 |